North Hollywood, CA, May 30, 2013—The International Myeloma Foundation (IMF) — improving the quality of life of myeloma patients while working toward prevention and a cure — will present the eleventh annual Robert A. Kyle Lifetime Achievement Award to Dr. Gösta Gahrton during a ceremony at the Grand Hotel in Stockholm, Sweden, on June 11, 2013.
Since 2003, the IMF has honored an outstanding physician each year with the award, which is named for its first recipient, Dr. Robert Kyle.
“We applaud Dr. Gahrton’s accomplishments and decades-long contributions to improving the lives of myeloma patients,” said IMF President and Co-Founder Susie Novis. Kyle Award honorees are individuals whose work in the field of myeloma has resulted in significant advances in research, treatment and care of myeloma patients.
The Kyle Award dovetails with the IMF’s mission to improve the lives of myeloma patients. Celebrating its 22nd anniversary, the IMF reaches out to more than 240,000 members in 120 countries worldwide and focuses on four key areas: research, education, support, and advocacy. To date, the IMF has conducted more than 250 educational seminars worldwide, maintains a world-renowned hotline, and established the International Myeloma Working Group (IMWG), a collaborative research initiative focused on improving myeloma treatment options for patients.
“Dr. Gahrton’s work perfectly reflects the words of Dr. William Mayo, founder of Mayo Clinic, who challenged the nature of patient care nearly a century ago when he said ‘The needs of the patient are the only needs to be considered,’ ” said Brian G.M. Durie, MD, Chairman and Co-Founder of the IMF.
Following graduation at the University of Lund, Dr. Gösta Gahrton joined the famous cell biologist Torbjörn Caspersson at the Karolinska Institutet and later professor Sidney Farber at Harvard Medical School in Boston. He became Ph.D on a thesis concerning cell biology of leukemia in 1966. After appointments at the Karolinska Hospital in Stockholm, he became Head of Hematology at Huddinge Hospital and Head of the Department of Medicine Karolinska Institutet. He was appointed professor of Medicine in 1985.
Dr. Gahrton has received several honors, among them the Trafvenfelt Diploma and the A.F. Regnell`s Prize by the Swedish Society of Medicine; Malthes Legat by the Norwegian Medical Society; the Ishan Dogramacy Award by the Hacettepe Univeristy Ankara; and the Louis Sullivan Award, Morehouse School of Medicine, Atlanta, Georgia. He is an honorary member of several International Societies and has been a member and chairman of the Nobel Committee of the Karolinska Institutet.
Gösta Gahrton has published more than 400 scientific articles in international scientific journals.
ABOUT THE INTERNATIONAL MYELOMA FOUNDATION
Celebrating its 22nd anniversary, the International Myeloma Foundation reaches more than 240,000 members in 120 countries worldwide. A 501 (c) 3 non-profit organization dedicated to improving the quality of life of myeloma patients and their families, the IMF focuses on four key areas: research, education, support, and advocacy. To date, the IMF has conducted more than 250 educational seminars worldwide, maintains a world-renowned hotline, and established the International Myeloma Working Group (IMWG), a collaborative research initiative focused on improving myeloma treatment options for patients. The IMF can be reached at (800) 452-CURE (2873). The global website is www.myeloma.org.